Related Experiment Videos
The nootropic compound BMY-21502 improves spatial learning ability in brain injured rats
J E Pierce1, D H Smith, M S Eison
1Center for Neurological Sciences, University of Connecticut Health Center, Farmington 06030.
Brain Research
|October 8, 1993
Summary
Traumatic brain injury (TBI) impairs learning. The nootropic BMY-21502 improved learning in TBI rats, but paradoxically worsened it in healthy controls, suggesting potential therapeutic use for TBI-related cognitive deficits.
Area of Science:
- Neuroscience
- Pharmacology
- Cognitive Science
Background:
- Traumatic brain injury (TBI) frequently leads to persistent cognitive dysfunction.
- Current pharmacological treatments for post-TBI cognitive deficits are limited.
- Previous research demonstrated TBI impairs retrograde memory in rats.
Purpose of the Study:
- To characterize learning impairments after lateral fluid-percussion (FP) brain injury in rats.
- To investigate the effects of the nootropic BMY-21502 on post-TBI learning deficits.
Main Methods:
- Male Sprague-Dawley rats underwent moderate lateral FP brain injury or sham surgery.
- Learning was assessed using the Morris water maze on days 7 and 8 post-injury.
- BMY-21502 (10 mg/kg) or vehicle was administered before trials.
Main Results:
- Vehicle-treated TBI rats showed significant learning impairment (P < 0.001) compared to sham controls.
- BMY-21502 treatment significantly improved learning in TBI rats (P < 0.05) versus vehicle.
- BMY-21502 appeared to impair learning in uninjured control animals.
Conclusions:
- BMY-21502 demonstrates potential for mitigating learning dysfunction following TBI.
- The drug's paradoxical effect in uninjured animals warrants further investigation.
- BMY-21502 may be a candidate for treating cognitive deficits after traumatic brain injury.